Filter
834
Text search:
vaccine
trial
Featured
Recommendations
91
New Publications
166
Language
Document type
No document type
351
Studies & Reports
175
Guidelines
155
Manuals
44
Fact sheets
41
Strategic & Response Plan
25
Training Material
15
Situation Updates
11
Resource Platforms
10
Videos
4
Brochures
1
App
1
Infographics
1
Countries / Regions
Global
41
India
28
Sierra Leone
18
Kenya
18
South Africa
17
Liberia
13
Uganda
13
West and Central Africa
13
Western and Central Europe
13
Brazil
12
East and Southern Africa
11
Africa
11
Russia
10
Ethiopia
9
Eastern Europe
9
Nigeria
8
Ghana
8
Zambia
8
Latin America and the Carribbean
8
Congo, Democratic Republic of
7
Philippines
7
South Sudan
7
Tanzania
7
Guinea
6
Zimbabwe
6
Rwanda
6
Nepal
5
Bangladesh
5
Mozambique
5
Middle East and North Africa
5
Germany
4
Malawi
4
Ukraine
4
Myanmar / Burma
4
Syria
3
Cambodia
3
Paraguay
3
Asia
3
Jordan
2
Lebanon
2
Thailand
2
Indonesia
2
Argentina
2
Namibia
2
Angola
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Burkina Faso
1
Guinea-Bissau
1
USA
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Turkey
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Botswana
1
Chile
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
France
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
210
Clinical Guidelines
108
Women & Child Health
56
Public Health
35
Key Resources
18
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
COVID-19
196
TB
74
HIV
67
Ebola & Marburg
51
NTDs
51
AMR
20
Malaria
20
Rapid Response
16
Pharmacy
15
Mental Health
14
Planetary Health
11
Global Health Education
10
Health Financing Toolbox
10
NCDs
10
Cholera
9
Refugee
8
Polio
7
Zika
7
Caregiver
6
2.0 Rapid Response
6
Conflict
5
Disability
2
Natural Hazards
1
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of pla
...
Lancet 2024; 403: 533–44
R21/Matrix-M was well tolerated and offered high efficacy against clinical malaria in African children. This
low-cost, high-efficacy vaccine is already licensed by several African countries, and recently received a WHO p
...
The Lancet, Early Online Publication, 11 July 2014
doi:10.1016/S0140-6736(14)60934-X
*Free registration is required to view this article
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Learn what scientists look for in the different phases of a clinical trial for a vaccine. What does it mean when a vaccine
...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19
...
Exciting news this week with @Pfizer reporting their mRNA vaccine is 90% effective, based on their Phase III clinical trial data. Dr. Tom looks inside the virus to break down how mRNA vaccines work,
...
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE)
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a
...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a
...
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a
...
COVID-19 Vaccine Resource Center
recommended
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated
...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate v
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.